Pyridostigmine kinetics with and without renal function

[1]  L. Sheiner,et al.  Renal Function and the Pharmacokinetics of Neostigmine in Anesthetized Man , 1979, Anesthesiology.

[2]  L. Benet,et al.  The pharmacokinetics of d-tubocurarine in man with and without renal failure. , 1977, The Journal of pharmacology and experimental therapeutics.

[3]  T. N. Calvey,et al.  Renal clearance of pyridostigmine in patients with myasthenia gravis. , 1977, European neurology.

[4]  R. Matteo,et al.  Enhancement of d-tuborcurarine neuromuscular blockade by diuretics in man. , 1977, Anesthesiology.

[5]  J. Baty,et al.  A quantitative gas-liquid chromatographic method for the determination of neostigmine and pyridostigmine in human plasma. , 1976, Journal of chromatography.

[6]  D. Cullen,et al.  Renal failure and postoperative respiratory failure: recurarization? , 1976, British journal of anaesthesia.

[7]  E. Eger,et al.  Comparative Times to Peak Effect and Durations of Action of Neostigmine and Pyridostigmine , 1974, Anesthesiology.

[8]  R. Miller,et al.  The Effect of Renal Failure and Hyperkalemia on the Duration of Pancuronium Neuromuscular Blockade in Man , 1973, Anesthesia and analgesia.

[9]  R. L. Wolf,et al.  Metabolism of 14C‐labeled pyridostigmine in myasthenia gravis , 1970, Neurology.

[10]  C. Pittinger,et al.  Antibiotic‐Induced Paralysis , 1970, Anesthesia and analgesia.

[11]  A. Wilson,et al.  The excretion and metabolism of oral 14C‐pyridostigmine in the rat , 1968, British journal of pharmacology.